MutualFundWire.com
The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication
an InvestmentWires' Publication
|
|
MutualFundWire.com
The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication |
|
Tuesday, May 21, 2024 Magoon Helps Investors Bet On the Weight-Loss Med Biz A Midwestern thematic fund shop's team is rolling out a new index fund to help investors bet on companies in the GLP-1 treatment business.
THNR's inception date is today, and it comes with an expense ratio of 59 basis points. The new fund is designed to track the VettaFi Weight Loss Drug & Treatment Index. TMX Group Limited's VettaFi LLC serves as THNR's index provider, Amplify Investments LLC serves as investment advisor, and Penserra Capital Management LLC serves as subadvisor. The new ETF's PM includes a Penserra trio: Anand Desai, senior vice president; Dustin Lewellyn, chief investment officer; and Ernesto Tong, managing director. "The launch of THNR aligns with our mission to provide innovative thematic investment solutions across new and existing market segments," Magoon states. "We view THNR as not just an investment in high growth pharmaceuticals but as an investment in a healthier future." THNR's other service providers include: Chapman and Cutler LLP as counsel; Cohen & Company, Ltd. as independent accounting firm; ACA's Foreside Fund Services, LLC as distributor; U.S. Bancorp Fund Services, LLC (dba U.S. Bank Global Fund Services) as administrator, fund accounting agent, and transfer agent; and U.S. Bank National Association as custodian and securities lending agent. Printed from: MFWire.com/story.asp?s=67448 Copyright 2024, InvestmentWires, Inc. All Rights Reserved |
